Improvement of Postprandial Endothelial Function After a Single Dose of Exenatide in Individuals With Impaired Glucose Tolerance and Recent-Onset Type 2 Diabetes
Authors:
Open Access
- 3 March 2010
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (5) , 1028-1030
Abstract
OBJECTIVE: Endothelial dysfunction is frequently present in individuals with insulin resistance or type 2 diabetes and can be induced by high-fat or high-carbohydrate meals. Because exenatide reduces postprandial glucose and lipid excursions, we hypothesized that it may also improve postprandial endothelial function. RESEARCH DESIGN AND METHODS: In a double-blinded randomized crossover design, postprandial endothelial function was examined in 28 individuals with impaired glucose tolerance or recent-onset type 2 diabetes after a single injection of exenatide or placebo given just before a high-fat meal. Endothelial function was determined with peripheral arterial tonometry pre- and postprandially. RESULTS: Postprandial endothelial function was higher after exenatide compared with placebo (P = 0.0002). In the placebo phase, postprandial change in endothelial function was inversely associated with mean postprandial concentrations of triglycerides (r = −0.62, P = 0.0004). Changes in postprandial triglyceride concentrations explained 64% of exenatide's effect on postprandial endothelial function. CONCLUSIONS: Exenatide ameliorates postprandial endothelial dysfunction after a high-fat meal.Keywords
This publication has 15 references indexed in Scilit:
- Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: A randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week studyClinical Therapeutics, 2008
- Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepirideAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 DiabetesThe Journal of Clinical Endocrinology & Metabolism, 2003
- Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive ratsJournal Of Hypertension, 2003
- Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery diseaseJACC, 2003
- Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress GenerationCirculation, 2002
- Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteersAmerican Journal of Physiology-Endocrinology and Metabolism, 2001
- Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.Journal of Clinical Investigation, 1996
- GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary arteryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 1993